Condition
Osteoarticular Infection
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Suspended1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05046860Not ApplicableActive Not RecruitingPrimary
Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements
NCT06627842SuspendedPrimary
OsteoArticular Sepsis in Intensive Care unitS
NCT01815541Phase 2CompletedPrimary
Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study
NCT02599493Phase 4CompletedPrimary
EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin
NCT01500837Not ApplicableCompletedPrimary
Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)
Showing all 5 trials